Literature DB >> 24299947

Surgical treatment of cervical arteriovenous fistula in a patient with neurofibromatosis type 1. A case report.

A Guzel1, M Tatli, U Er, A Kazanci, H M Ozturk, D Belen.   

Abstract

Vasculopathies are frequently associated with neurofibromatosis type-1, and they are generally occlusive or stenotic type lesions. Vertebral arteriovenous fistula (AVF) is quite rare in neurofibromatosis type 1 patients. They can be treated with surgical excision or endovascular occlusion. We describe a surgically treated cervical AVF in a neurofibromatosis type 1 (NF-1) patient and discuss the selection of the patient for the surgery. Although endovascular occlusion is the first line treatment option for cervical AVFs, some selected cases can be successfully treated by surgery. Surgery should be considered as a treatment option in spite of its risks, especially for cervical AVF which is associated with fibromuscular system diseases like NF-1.

Entities:  

Year:  2007        PMID: 24299947     DOI: 10.1177/197140090702000515

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  3 in total

Review 1.  Neurovascular manifestations of connective-tissue diseases: A review.

Authors:  Sarasa T Kim; Waleed Brinjikji; Giuseppe Lanzino; David F Kallmes
Journal:  Interv Neuroradiol       Date:  2016-08-10       Impact factor: 1.610

2.  Vertebral arteriovenous fistulae (AVF) and vertebral artery aneurysms in neurofibromatosis type 1: A case report and a systematic review.

Authors:  Jiali Zhao; Guangyu Zhao; Lin Lu; Chunxia Li; Ruirui Yang
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

3.  Subarachnoid Hemorrhage from Vertebral Arteriovenous Fistula without Perimedullary Drainage: Rare Stroke Hemorrhagic Event in a Patient of Neurofibromatosis Type 1.

Authors:  Yoshinori Maki; Ryota Ishibashi; Hitoshi Fukuda; Miyako Kobayashi; Masaki Chin; Sen Yamagata
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-02-23       Impact factor: 1.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.